Target intelligence / Profile preview

Beclin 1–phosphatidylinositol 3-kinase catalytic subunit type 3 complex (Beclin 1–Vps34 complex)

Target
Beclin 1–Vps34 complex
Molecular classification
Multi-protein complex, Lipid kinase regulator, Other
01

Overview

The Beclin 1–Vps34 complex is a core multi-protein assembly essential for the initiation of autophagy and endocytic trafficking in mammalian cells. It consists primarily of Beclin 1 (BECN1), a scaffold protein, and Vps34 (phosphatidylinositol 3-kinase catalytic subunit type 3, PIK3C3), a lipid kinase. The complex also includes regulatory subunits such as Vps15 (PIK3R4), ATG14 or UVRAG, and sometimes accessory proteins like NRBF2. The Beclin 1–Vps34 complex catalyzes the generation of PtdIns(3)P, a lipid signal crucial for recruiting proteins that mediate autophagosome biogenesis and membrane trafficking. Distinct combinatorial assemblies (Beclin 1–Vps34–ATG14 and Beclin 1–Vps34–UVRAG) direct the complex toward autophagy versus endocytosis, respectively. Dysregulation of this complex is implicated in cancer, neurodegenerative diseases, and infections. The complex is a validated therapeutic target for modulating autophagy, though direct pharmacological targeting is still experimental. Inhibitors of VPS34 kinase activity are being developed as modulators of autophagy in disease contexts[1][2][5][4][6].

Other names
Beclin 1–PIK3C3 complexBeclin 1–Class III PI3K complexBECN1–Vps34 complexAtg6–Vps34 complex
02

Mechanism of action

Inhibition of phosphatidylinositol 3-phosphate (PtdIns-3P) synthesis; Modulation of autophagy initiation; Disruption of autophagosome formation

03

Biological functions

Autophagy regulationMembrane traffickingEndocytic traffickingCell survivalCell death
04

Disease associations

CancerNeurodegenerative diseaseInfectionInflammationOther
05

Safety considerations

Disruption of autophagy can lead to cell death and increased susceptibility to cellular stressPotential for promoting neurodegeneration or tumorigenesis depending on contextGeneral risks associated with impairing cell survival pathways
06

Interacting drugs

VPS34 inhibitors (no approved drugs, but experimental inhibitors like VPS34-IN1 and SAR405 are reported)

1 more in the full profile.

07

Biomarkers

PtdIns(3)P levels (as a marker of autophagic activity)Beclin 1 expressionLC3/Atg8 lipidation (indirect marker)

Beyond the preview

Go deeper on Beclin 1–phosphatidylinositol 3-kinase catalytic subunit type 3 complex (Beclin 1–Vps34 complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beclin 1–phosphatidylinositol 3-kinase catalytic subunit type 3 complex (Beclin 1–Vps34 complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call